nodes	percent_of_prediction	percent_of_DWPC	metapath
Nicardipine—CYP2B6—malignant glioma	0.581	1	CbGaD
Nicardipine—Disease progression—Carmustine—malignant glioma	0.00795	0.0943	CcSEcCtD
Nicardipine—CALM2—pons—malignant glioma	0.0041	0.0417	CbGeAlD
Nicardipine—Haemorrhage intracranial—Temozolomide—malignant glioma	0.00409	0.0485	CcSEcCtD
Nicardipine—CALM1—pons—malignant glioma	0.00408	0.0415	CbGeAlD
Nicardipine—Cerebral ischaemia—Temozolomide—malignant glioma	0.00347	0.0412	CcSEcCtD
Nicardipine—CALM2—pineal body—malignant glioma	0.00293	0.0298	CbGeAlD
Nicardipine—CALM1—pineal body—malignant glioma	0.00291	0.0296	CbGeAlD
Nicardipine—Deep vein thrombosis—Temozolomide—malignant glioma	0.00276	0.0327	CcSEcCtD
Nicardipine—PDE1B—telencephalon—malignant glioma	0.00247	0.0251	CbGeAlD
Nicardipine—PDE1A—brainstem—malignant glioma	0.00233	0.0237	CbGeAlD
Nicardipine—Injection site pain—Carmustine—malignant glioma	0.00212	0.0252	CcSEcCtD
Nicardipine—PDE1A—telencephalon—malignant glioma	0.00207	0.0211	CbGeAlD
Nicardipine—CALM2—endothelium—malignant glioma	0.00181	0.0184	CbGeAlD
Nicardipine—CALM1—endothelium—malignant glioma	0.0018	0.0183	CbGeAlD
Nicardipine—Neck pain—Carmustine—malignant glioma	0.00176	0.0208	CcSEcCtD
Nicardipine—Injection site reaction—Carmustine—malignant glioma	0.00172	0.0205	CcSEcCtD
Nicardipine—CALM2—blood vessel—malignant glioma	0.00167	0.017	CbGeAlD
Nicardipine—CALM1—blood vessel—malignant glioma	0.00166	0.0169	CbGeAlD
Nicardipine—CACNB2—retina—malignant glioma	0.00166	0.0169	CbGeAlD
Nicardipine—PDE1A—medulla oblongata—malignant glioma	0.00163	0.0165	CbGeAlD
Nicardipine—CACNA2D1—brainstem—malignant glioma	0.00162	0.0164	CbGeAlD
Nicardipine—CACNB2—telencephalon—malignant glioma	0.00153	0.0155	CbGeAlD
Nicardipine—Abnormal vision—Carmustine—malignant glioma	0.00151	0.018	CcSEcCtD
Nicardipine—PDE1A—midbrain—malignant glioma	0.00149	0.0151	CbGeAlD
Nicardipine—Abnormal vision—Temozolomide—malignant glioma	0.00146	0.0173	CcSEcCtD
Nicardipine—PDE1A—spinal cord—malignant glioma	0.00145	0.0147	CbGeAlD
Nicardipine—PDE1B—central nervous system—malignant glioma	0.0014	0.0143	CbGeAlD
Nicardipine—PDE1B—cerebellum—malignant glioma	0.00137	0.014	CbGeAlD
Nicardipine—CACNA1D—telencephalon—malignant glioma	0.00133	0.0136	CbGeAlD
Nicardipine—ADRA1D—telencephalon—malignant glioma	0.00132	0.0135	CbGeAlD
Nicardipine—Hot flush—Temozolomide—malignant glioma	0.0013	0.0154	CcSEcCtD
Nicardipine—Menopausal symptoms—Temozolomide—malignant glioma	0.00129	0.0153	CcSEcCtD
Nicardipine—CACNA1C—telencephalon—malignant glioma	0.00123	0.0125	CbGeAlD
Nicardipine—Face oedema—Carmustine—malignant glioma	0.00122	0.0144	CcSEcCtD
Nicardipine—PDE1A—central nervous system—malignant glioma	0.00118	0.012	CbGeAlD
Nicardipine—Face oedema—Temozolomide—malignant glioma	0.00117	0.0139	CcSEcCtD
Nicardipine—PDE1A—cerebellum—malignant glioma	0.00115	0.0117	CbGeAlD
Nicardipine—Hypokalaemia—Carmustine—malignant glioma	0.00115	0.0136	CcSEcCtD
Nicardipine—CALM3—retina—malignant glioma	0.00112	0.0114	CbGeAlD
Nicardipine—PDE1B—brain—malignant glioma	0.00111	0.0113	CbGeAlD
Nicardipine—Hypokalaemia—Temozolomide—malignant glioma	0.00111	0.0131	CcSEcCtD
Nicardipine—CHRM4—central nervous system—malignant glioma	0.00108	0.0109	CbGeAlD
Nicardipine—CALM3—telencephalon—malignant glioma	0.00103	0.0105	CbGeAlD
Nicardipine—Sweating increased—Temozolomide—malignant glioma	0.00102	0.0122	CcSEcCtD
Nicardipine—CHRM2—telencephalon—malignant glioma	0.00102	0.0103	CbGeAlD
Nicardipine—CALM2—embryo—malignant glioma	0.000996	0.0101	CbGeAlD
Nicardipine—CALM1—embryo—malignant glioma	0.000991	0.0101	CbGeAlD
Nicardipine—Pollakiuria—Temozolomide—malignant glioma	0.000972	0.0115	CcSEcCtD
Nicardipine—Erectile dysfunction—Temozolomide—malignant glioma	0.000969	0.0115	CcSEcCtD
Nicardipine—PDE1A—brain—malignant glioma	0.000934	0.0095	CbGeAlD
Nicardipine—CHRM1—telencephalon—malignant glioma	0.000925	0.0094	CbGeAlD
Nicardipine—CALM2—brainstem—malignant glioma	0.000913	0.00928	CbGeAlD
Nicardipine—CALM1—brainstem—malignant glioma	0.000909	0.00924	CbGeAlD
Nicardipine—CALM2—retina—malignant glioma	0.000881	0.00895	CbGeAlD
Nicardipine—Sinusitis—Temozolomide—malignant glioma	0.00088	0.0104	CcSEcCtD
Nicardipine—CALM1—retina—malignant glioma	0.000876	0.00891	CbGeAlD
Nicardipine—CACNB2—central nervous system—malignant glioma	0.000867	0.00882	CbGeAlD
Nicardipine—Hypoaesthesia—Carmustine—malignant glioma	0.000867	0.0103	CcSEcCtD
Nicardipine—Clevidipine—BCHE—malignant glioma	0.000862	0.358	CrCbGaD
Nicardipine—Oedema peripheral—Carmustine—malignant glioma	0.000858	0.0102	CcSEcCtD
Nicardipine—ADRA1A—brainstem—malignant glioma	0.000856	0.0087	CbGeAlD
Nicardipine—CHRM4—brain—malignant glioma	0.000854	0.00869	CbGeAlD
Nicardipine—CACNB2—cerebellum—malignant glioma	0.000848	0.00862	CbGeAlD
Nicardipine—CHRM5—central nervous system—malignant glioma	0.000841	0.00855	CbGeAlD
Nicardipine—Visual impairment—Carmustine—malignant glioma	0.00084	0.00996	CcSEcCtD
Nicardipine—Hypoaesthesia—Temozolomide—malignant glioma	0.000838	0.00994	CcSEcCtD
Nicardipine—Oedema peripheral—Temozolomide—malignant glioma	0.000829	0.00984	CcSEcCtD
Nicardipine—CHRM3—telencephalon—malignant glioma	0.000827	0.00841	CbGeAlD
Nicardipine—Amlodipine—CYP2B6—malignant glioma	0.000815	0.339	CrCbGaD
Nicardipine—CACNA2D1—central nervous system—malignant glioma	0.000815	0.00828	CbGeAlD
Nicardipine—Visual impairment—Temozolomide—malignant glioma	0.000811	0.00963	CcSEcCtD
Nicardipine—CALM3—medulla oblongata—malignant glioma	0.00081	0.00824	CbGeAlD
Nicardipine—CALM2—telencephalon—malignant glioma	0.00081	0.00824	CbGeAlD
Nicardipine—Flushing—Carmustine—malignant glioma	0.000809	0.00959	CcSEcCtD
Nicardipine—CALM1—telencephalon—malignant glioma	0.000806	0.0082	CbGeAlD
Nicardipine—CACNA2D1—cerebellum—malignant glioma	0.000796	0.0081	CbGeAlD
Nicardipine—Tinnitus—Temozolomide—malignant glioma	0.000785	0.00931	CcSEcCtD
Nicardipine—Flushing—Temozolomide—malignant glioma	0.000781	0.00927	CcSEcCtD
Nicardipine—ADRA1B—central nervous system—malignant glioma	0.000769	0.00782	CbGeAlD
Nicardipine—ADRA1A—telencephalon—malignant glioma	0.00076	0.00773	CbGeAlD
Nicardipine—CACNA1D—central nervous system—malignant glioma	0.000758	0.00771	CbGeAlD
Nicardipine—ADRA1D—central nervous system—malignant glioma	0.000752	0.00765	CbGeAlD
Nicardipine—CACNA1D—cerebellum—malignant glioma	0.000741	0.00754	CbGeAlD
Nicardipine—CALM3—midbrain—malignant glioma	0.000741	0.00753	CbGeAlD
Nicardipine—Nifedipine—CYP2B6—malignant glioma	0.000729	0.303	CrCbGaD
Nicardipine—CALM3—spinal cord—malignant glioma	0.000723	0.00735	CbGeAlD
Nicardipine—Vision blurred—Carmustine—malignant glioma	0.000715	0.00848	CcSEcCtD
Nicardipine—Tremor—Carmustine—malignant glioma	0.000711	0.00843	CcSEcCtD
Nicardipine—CACNA1C—central nervous system—malignant glioma	0.0007	0.00712	CbGeAlD
Nicardipine—Agitation—Carmustine—malignant glioma	0.000697	0.00827	CcSEcCtD
Nicardipine—Vision blurred—Temozolomide—malignant glioma	0.000691	0.0082	CcSEcCtD
Nicardipine—CACNB2—brain—malignant glioma	0.000689	0.007	CbGeAlD
Nicardipine—Tremor—Temozolomide—malignant glioma	0.000687	0.00815	CcSEcCtD
Nicardipine—CACNA1C—cerebellum—malignant glioma	0.000684	0.00696	CbGeAlD
Nicardipine—Ill-defined disorder—Temozolomide—malignant glioma	0.00068	0.00807	CcSEcCtD
Nicardipine—Agitation—Temozolomide—malignant glioma	0.000673	0.00799	CcSEcCtD
Nicardipine—CHRM5—brain—malignant glioma	0.000668	0.00679	CbGeAlD
Nicardipine—ABCB1—blood vessel—malignant glioma	0.000663	0.00675	CbGeAlD
Nicardipine—Malaise—Temozolomide—malignant glioma	0.000661	0.00784	CcSEcCtD
Nicardipine—Vertigo—Temozolomide—malignant glioma	0.000658	0.00781	CcSEcCtD
Nicardipine—Hypertension—Carmustine—malignant glioma	0.000655	0.00777	CcSEcCtD
Nicardipine—Palpitations—Temozolomide—malignant glioma	0.000648	0.00768	CcSEcCtD
Nicardipine—CACNA2D1—brain—malignant glioma	0.000647	0.00658	CbGeAlD
Nicardipine—Chest pain—Carmustine—malignant glioma	0.000646	0.00766	CcSEcCtD
Nicardipine—Myalgia—Carmustine—malignant glioma	0.000646	0.00766	CcSEcCtD
Nicardipine—Anxiety—Carmustine—malignant glioma	0.000643	0.00763	CcSEcCtD
Nicardipine—CALM2—medulla oblongata—malignant glioma	0.000636	0.00647	CbGeAlD
Nicardipine—CALM1—medulla oblongata—malignant glioma	0.000633	0.00644	CbGeAlD
Nicardipine—Hypertension—Temozolomide—malignant glioma	0.000633	0.00751	CcSEcCtD
Nicardipine—Confusional state—Carmustine—malignant glioma	0.000624	0.0074	CcSEcCtD
Nicardipine—Myalgia—Temozolomide—malignant glioma	0.000624	0.0074	CcSEcCtD
Nicardipine—Arthralgia—Temozolomide—malignant glioma	0.000624	0.0074	CcSEcCtD
Nicardipine—Anxiety—Temozolomide—malignant glioma	0.000622	0.00738	CcSEcCtD
Nicardipine—Oedema—Carmustine—malignant glioma	0.000619	0.00734	CcSEcCtD
Nicardipine—Discomfort—Temozolomide—malignant glioma	0.000616	0.00731	CcSEcCtD
Nicardipine—Infection—Carmustine—malignant glioma	0.000615	0.0073	CcSEcCtD
Nicardipine—Dry mouth—Temozolomide—malignant glioma	0.00061	0.00724	CcSEcCtD
Nicardipine—ADRA1B—brain—malignant glioma	0.00061	0.0062	CbGeAlD
Nicardipine—Thrombocytopenia—Carmustine—malignant glioma	0.000606	0.00719	CcSEcCtD
Nicardipine—Tachycardia—Carmustine—malignant glioma	0.000604	0.00717	CcSEcCtD
Nicardipine—Confusional state—Temozolomide—malignant glioma	0.000603	0.00716	CcSEcCtD
Nicardipine—CACNA1D—brain—malignant glioma	0.000602	0.00612	CbGeAlD
Nicardipine—Oedema—Temozolomide—malignant glioma	0.000598	0.0071	CcSEcCtD
Nicardipine—ADRA1D—brain—malignant glioma	0.000597	0.00607	CbGeAlD
Nicardipine—Infection—Temozolomide—malignant glioma	0.000594	0.00705	CcSEcCtD
Nicardipine—Thrombocytopenia—Temozolomide—malignant glioma	0.000586	0.00695	CcSEcCtD
Nicardipine—CALM2—midbrain—malignant glioma	0.000582	0.00591	CbGeAlD
Nicardipine—CALM1—midbrain—malignant glioma	0.000579	0.00589	CbGeAlD
Nicardipine—Hypotension—Carmustine—malignant glioma	0.000578	0.00686	CcSEcCtD
Nicardipine—Hyperhidrosis—Temozolomide—malignant glioma	0.000578	0.00686	CcSEcCtD
Nicardipine—CHRM2—central nervous system—malignant glioma	0.000577	0.00587	CbGeAlD
Nicardipine—CALM3—cerebellum—malignant glioma	0.000573	0.00583	CbGeAlD
Nicardipine—CALM2—spinal cord—malignant glioma	0.000568	0.00577	CbGeAlD
Nicardipine—CYP2E1—telencephalon—malignant glioma	0.000565	0.00575	CbGeAlD
Nicardipine—CALM1—spinal cord—malignant glioma	0.000565	0.00574	CbGeAlD
Nicardipine—Musculoskeletal discomfort—Carmustine—malignant glioma	0.000564	0.00669	CcSEcCtD
Nicardipine—Insomnia—Carmustine—malignant glioma	0.00056	0.00664	CcSEcCtD
Nicardipine—Paraesthesia—Carmustine—malignant glioma	0.000556	0.00659	CcSEcCtD
Nicardipine—CACNA1C—brain—malignant glioma	0.000556	0.00565	CbGeAlD
Nicardipine—Dyspnoea—Carmustine—malignant glioma	0.000552	0.00655	CcSEcCtD
Nicardipine—Somnolence—Carmustine—malignant glioma	0.00055	0.00653	CcSEcCtD
Nicardipine—Musculoskeletal discomfort—Temozolomide—malignant glioma	0.000545	0.00647	CcSEcCtD
Nicardipine—Insomnia—Temozolomide—malignant glioma	0.000541	0.00642	CcSEcCtD
Nicardipine—Paraesthesia—Temozolomide—malignant glioma	0.000537	0.00637	CcSEcCtD
Nicardipine—Dyspnoea—Temozolomide—malignant glioma	0.000533	0.00633	CcSEcCtD
Nicardipine—Somnolence—Temozolomide—malignant glioma	0.000532	0.00631	CcSEcCtD
Nicardipine—Pain—Carmustine—malignant glioma	0.000529	0.00628	CcSEcCtD
Nicardipine—Constipation—Carmustine—malignant glioma	0.000529	0.00628	CcSEcCtD
Nicardipine—Dyspepsia—Temozolomide—malignant glioma	0.000527	0.00625	CcSEcCtD
Nicardipine—CHRM1—central nervous system—malignant glioma	0.000526	0.00534	CbGeAlD
Nicardipine—Pain—Temozolomide—malignant glioma	0.000511	0.00607	CcSEcCtD
Nicardipine—Constipation—Temozolomide—malignant glioma	0.000511	0.00607	CcSEcCtD
Nicardipine—Feeling abnormal—Carmustine—malignant glioma	0.00051	0.00605	CcSEcCtD
Nicardipine—Gastrointestinal pain—Carmustine—malignant glioma	0.000506	0.00601	CcSEcCtD
Nicardipine—CYP2D6—brainstem—malignant glioma	0.000504	0.00513	CbGeAlD
Nicardipine—Feeling abnormal—Temozolomide—malignant glioma	0.000493	0.00585	CcSEcCtD
Nicardipine—Body temperature increased—Carmustine—malignant glioma	0.000489	0.00581	CcSEcCtD
Nicardipine—Abdominal pain—Carmustine—malignant glioma	0.000489	0.00581	CcSEcCtD
Nicardipine—Gastrointestinal pain—Temozolomide—malignant glioma	0.000489	0.0058	CcSEcCtD
Nicardipine—Body temperature increased—Temozolomide—malignant glioma	0.000473	0.00561	CcSEcCtD
Nicardipine—Abdominal pain—Temozolomide—malignant glioma	0.000473	0.00561	CcSEcCtD
Nicardipine—CHRM3—central nervous system—malignant glioma	0.00047	0.00478	CbGeAlD
Nicardipine—CALM3—brain—malignant glioma	0.000465	0.00473	CbGeAlD
Nicardipine—CALM2—central nervous system—malignant glioma	0.00046	0.00468	CbGeAlD
Nicardipine—CHRM2—brain—malignant glioma	0.000458	0.00466	CbGeAlD
Nicardipine—CALM1—central nervous system—malignant glioma	0.000458	0.00466	CbGeAlD
Nicardipine—Hypersensitivity—Carmustine—malignant glioma	0.000456	0.00541	CcSEcCtD
Nicardipine—CALM2—cerebellum—malignant glioma	0.00045	0.00458	CbGeAlD
Nicardipine—CALM1—cerebellum—malignant glioma	0.000448	0.00455	CbGeAlD
Nicardipine—CYP2D6—telencephalon—malignant glioma	0.000447	0.00455	CbGeAlD
Nicardipine—Asthenia—Carmustine—malignant glioma	0.000444	0.00527	CcSEcCtD
Nicardipine—CYP2E1—medulla oblongata—malignant glioma	0.000444	0.00452	CbGeAlD
Nicardipine—Hypersensitivity—Temozolomide—malignant glioma	0.000441	0.00523	CcSEcCtD
Nicardipine—ADRA1A—central nervous system—malignant glioma	0.000432	0.00439	CbGeAlD
Nicardipine—Asthenia—Temozolomide—malignant glioma	0.000429	0.00509	CcSEcCtD
Nicardipine—Diarrhoea—Carmustine—malignant glioma	0.000423	0.00502	CcSEcCtD
Nicardipine—ADRA1A—cerebellum—malignant glioma	0.000422	0.00429	CbGeAlD
Nicardipine—CHRM1—brain—malignant glioma	0.000417	0.00424	CbGeAlD
Nicardipine—Dizziness—Carmustine—malignant glioma	0.000409	0.00486	CcSEcCtD
Nicardipine—Diarrhoea—Temozolomide—malignant glioma	0.000409	0.00486	CcSEcCtD
Nicardipine—CYP2E1—spinal cord—malignant glioma	0.000396	0.00403	CbGeAlD
Nicardipine—ABCB1—embryo—malignant glioma	0.000396	0.00402	CbGeAlD
Nicardipine—Dizziness—Temozolomide—malignant glioma	0.000396	0.00469	CcSEcCtD
Nicardipine—Vomiting—Carmustine—malignant glioma	0.000394	0.00467	CcSEcCtD
Nicardipine—Rash—Carmustine—malignant glioma	0.00039	0.00463	CcSEcCtD
Nicardipine—Dermatitis—Carmustine—malignant glioma	0.00039	0.00463	CcSEcCtD
Nicardipine—Headache—Carmustine—malignant glioma	0.000388	0.0046	CcSEcCtD
Nicardipine—Vomiting—Temozolomide—malignant glioma	0.00038	0.00451	CcSEcCtD
Nicardipine—Rash—Temozolomide—malignant glioma	0.000377	0.00447	CcSEcCtD
Nicardipine—Dermatitis—Temozolomide—malignant glioma	0.000377	0.00447	CcSEcCtD
Nicardipine—Headache—Temozolomide—malignant glioma	0.000375	0.00445	CcSEcCtD
Nicardipine—CHRM3—brain—malignant glioma	0.000373	0.0038	CbGeAlD
Nicardipine—Nausea—Carmustine—malignant glioma	0.000368	0.00436	CcSEcCtD
Nicardipine—CALM2—brain—malignant glioma	0.000366	0.00372	CbGeAlD
Nicardipine—CALM1—brain—malignant glioma	0.000364	0.0037	CbGeAlD
Nicardipine—Nausea—Temozolomide—malignant glioma	0.000355	0.00422	CcSEcCtD
Nicardipine—ABCB1—retina—malignant glioma	0.00035	0.00356	CbGeAlD
Nicardipine—ADRA1A—brain—malignant glioma	0.000343	0.00349	CbGeAlD
Nicardipine—CYP2B6—central nervous system—malignant glioma	0.000342	0.00348	CbGeAlD
Nicardipine—ABCB1—telencephalon—malignant glioma	0.000322	0.00327	CbGeAlD
Nicardipine—CYP2E1—central nervous system—malignant glioma	0.000321	0.00327	CbGeAlD
Nicardipine—CYP2E1—cerebellum—malignant glioma	0.000314	0.00319	CbGeAlD
Nicardipine—CYP2C8—brain—malignant glioma	0.000303	0.00308	CbGeAlD
Nicardipine—CYP2B6—brain—malignant glioma	0.000272	0.00276	CbGeAlD
Nicardipine—CYP3A4—central nervous system—malignant glioma	0.000258	0.00263	CbGeAlD
Nicardipine—CYP2E1—brain—malignant glioma	0.000255	0.00259	CbGeAlD
Nicardipine—CYP2D6—central nervous system—malignant glioma	0.000254	0.00259	CbGeAlD
Nicardipine—ABCB1—medulla oblongata—malignant glioma	0.000253	0.00257	CbGeAlD
Nicardipine—CYP2D6—cerebellum—malignant glioma	0.000249	0.00253	CbGeAlD
Nicardipine—ABCB1—midbrain—malignant glioma	0.000231	0.00235	CbGeAlD
Nicardipine—ABCB1—spinal cord—malignant glioma	0.000226	0.00229	CbGeAlD
Nicardipine—CYP2D6—brain—malignant glioma	0.000202	0.00205	CbGeAlD
Nicardipine—ABCB1—central nervous system—malignant glioma	0.000183	0.00186	CbGeAlD
Nicardipine—ABCB1—cerebellum—malignant glioma	0.000179	0.00182	CbGeAlD
Nicardipine—ABCB1—brain—malignant glioma	0.000145	0.00148	CbGeAlD
Nicardipine—ADRA1B—Signaling Pathways—MMP9—malignant glioma	4.05e-06	1.73e-05	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—CXCL8—malignant glioma	4.04e-06	1.73e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling by GPCR—EGFR—malignant glioma	4.04e-06	1.72e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling by GPCR—EGFR—malignant glioma	4.04e-06	1.72e-05	CbGpPWpGaD
Nicardipine—ADRA1D—Signaling Pathways—MYC—malignant glioma	4.04e-06	1.72e-05	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—CXCL8—malignant glioma	4.03e-06	1.72e-05	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling Pathways—PTEN—malignant glioma	4.03e-06	1.72e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—PIK3CD—malignant glioma	4.03e-06	1.72e-05	CbGpPWpGaD
Nicardipine—CALM1—Metabolism—PTGS2—malignant glioma	4.03e-06	1.72e-05	CbGpPWpGaD
Nicardipine—CALM2—Metabolism—PTGS2—malignant glioma	4.03e-06	1.72e-05	CbGpPWpGaD
Nicardipine—ABCB1—Metabolism—PPARG—malignant glioma	4.01e-06	1.71e-05	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—CXCL8—malignant glioma	3.99e-06	1.7e-05	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—CXCL8—malignant glioma	3.98e-06	1.7e-05	CbGpPWpGaD
Nicardipine—CHRM5—Signaling Pathways—KRAS—malignant glioma	3.97e-06	1.69e-05	CbGpPWpGaD
Nicardipine—ADRA1D—Signaling Pathways—EGFR—malignant glioma	3.95e-06	1.68e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling by GPCR—KRAS—malignant glioma	3.94e-06	1.68e-05	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling by GPCR—AKT1—malignant glioma	3.93e-06	1.68e-05	CbGpPWpGaD
Nicardipine—CYP2D6—Metabolism—PIK3CG—malignant glioma	3.91e-06	1.67e-05	CbGpPWpGaD
Nicardipine—CHRM1—GPCR downstream signaling—AKT1—malignant glioma	3.91e-06	1.67e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—PIK3CD—malignant glioma	3.9e-06	1.66e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—PIK3CD—malignant glioma	3.9e-06	1.66e-05	CbGpPWpGaD
Nicardipine—CHRM3—GPCR downstream signaling—AKT1—malignant glioma	3.89e-06	1.66e-05	CbGpPWpGaD
Nicardipine—CYP2C9—Metabolism—PIK3CG—malignant glioma	3.88e-06	1.66e-05	CbGpPWpGaD
Nicardipine—CALM3—Disease—STAT3—malignant glioma	3.88e-06	1.65e-05	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—CASP3—malignant glioma	3.87e-06	1.65e-05	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—IL2—malignant glioma	3.86e-06	1.65e-05	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—CASP3—malignant glioma	3.86e-06	1.65e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—FGF2—malignant glioma	3.86e-06	1.65e-05	CbGpPWpGaD
Nicardipine—CHRM2—GPCR downstream signaling—AKT1—malignant glioma	3.86e-06	1.65e-05	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—IL2—malignant glioma	3.85e-06	1.64e-05	CbGpPWpGaD
Nicardipine—ADRA1A—GPCR downstream signaling—AKT1—malignant glioma	3.85e-06	1.64e-05	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—CASP3—malignant glioma	3.82e-06	1.63e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling by GPCR—KRAS—malignant glioma	3.82e-06	1.63e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling by GPCR—KRAS—malignant glioma	3.82e-06	1.63e-05	CbGpPWpGaD
Nicardipine—CALM3—Immune System—EGFR—malignant glioma	3.82e-06	1.63e-05	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—IL2—malignant glioma	3.82e-06	1.63e-05	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—CASP3—malignant glioma	3.81e-06	1.63e-05	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—IL2—malignant glioma	3.8e-06	1.62e-05	CbGpPWpGaD
Nicardipine—CHRM4—Signaling Pathways—PIK3CA—malignant glioma	3.8e-06	1.62e-05	CbGpPWpGaD
Nicardipine—CYP2D6—Metabolism—PPARG—malignant glioma	3.78e-06	1.61e-05	CbGpPWpGaD
Nicardipine—CYP3A4—Metabolism—GSTP1—malignant glioma	3.75e-06	1.6e-05	CbGpPWpGaD
Nicardipine—CALM1—Disease—STAT3—malignant glioma	3.75e-06	1.6e-05	CbGpPWpGaD
Nicardipine—CALM2—Disease—STAT3—malignant glioma	3.75e-06	1.6e-05	CbGpPWpGaD
Nicardipine—CYP2C9—Metabolism—PPARG—malignant glioma	3.75e-06	1.6e-05	CbGpPWpGaD
Nicardipine—CYP2C19—Metabolism—PIK3CD—malignant glioma	3.74e-06	1.6e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—FGF2—malignant glioma	3.73e-06	1.59e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—FGF2—malignant glioma	3.73e-06	1.59e-05	CbGpPWpGaD
Nicardipine—CYP2B6—Metabolism—PTEN—malignant glioma	3.73e-06	1.59e-05	CbGpPWpGaD
Nicardipine—ADRA1D—Signaling Pathways—KRAS—malignant glioma	3.73e-06	1.59e-05	CbGpPWpGaD
Nicardipine—CALM2—Immune System—EGFR—malignant glioma	3.69e-06	1.58e-05	CbGpPWpGaD
Nicardipine—CALM1—Immune System—EGFR—malignant glioma	3.69e-06	1.58e-05	CbGpPWpGaD
Nicardipine—CHRM4—Signaling Pathways—TP53—malignant glioma	3.68e-06	1.57e-05	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—MMP9—malignant glioma	3.66e-06	1.56e-05	CbGpPWpGaD
Nicardipine—CYP2C8—Metabolism—PIK3CB—malignant glioma	3.65e-06	1.56e-05	CbGpPWpGaD
Nicardipine—CYP2E1—Metabolism—PTEN—malignant glioma	3.65e-06	1.56e-05	CbGpPWpGaD
Nicardipine—ABCB1—Metabolism—PIK3CD—malignant glioma	3.65e-06	1.56e-05	CbGpPWpGaD
Nicardipine—CYP3A4—Metabolism—CAT—malignant glioma	3.65e-06	1.56e-05	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—MMP9—malignant glioma	3.65e-06	1.56e-05	CbGpPWpGaD
Nicardipine—CYP3A5—Metabolism—PTEN—malignant glioma	3.65e-06	1.56e-05	CbGpPWpGaD
Nicardipine—CHRM5—Signaling Pathways—PIK3CA—malignant glioma	3.64e-06	1.56e-05	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling Pathways—VEGFA—malignant glioma	3.64e-06	1.55e-05	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—PTEN—malignant glioma	3.64e-06	1.55e-05	CbGpPWpGaD
Nicardipine—CALM3—Metabolism—PTEN—malignant glioma	3.63e-06	1.55e-05	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—PTEN—malignant glioma	3.62e-06	1.55e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling by GPCR—PIK3CA—malignant glioma	3.62e-06	1.55e-05	CbGpPWpGaD
Nicardipine—CYP2C8—Metabolism—PTGS2—malignant glioma	3.62e-06	1.55e-05	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—MMP9—malignant glioma	3.61e-06	1.54e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—MDM2—malignant glioma	3.61e-06	1.54e-05	CbGpPWpGaD
Nicardipine—CALM3—Immune System—KRAS—malignant glioma	3.6e-06	1.54e-05	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling Pathways—STAT3—malignant glioma	3.6e-06	1.54e-05	CbGpPWpGaD
Nicardipine—CALM3—Disease—MYC—malignant glioma	3.6e-06	1.54e-05	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—MMP9—malignant glioma	3.6e-06	1.54e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—RAF1—malignant glioma	3.6e-06	1.54e-05	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—PTEN—malignant glioma	3.59e-06	1.53e-05	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—PTEN—malignant glioma	3.58e-06	1.53e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—ERBB2—malignant glioma	3.56e-06	1.52e-05	CbGpPWpGaD
Nicardipine—CHRM1—Signaling by GPCR—AKT1—malignant glioma	3.55e-06	1.51e-05	CbGpPWpGaD
Nicardipine—CHRM3—Signaling by GPCR—AKT1—malignant glioma	3.54e-06	1.51e-05	CbGpPWpGaD
Nicardipine—CHRM5—Signaling Pathways—TP53—malignant glioma	3.52e-06	1.5e-05	CbGpPWpGaD
Nicardipine—CALM3—Disease—EGFR—malignant glioma	3.52e-06	1.5e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—PIK3CB—malignant glioma	3.51e-06	1.5e-05	CbGpPWpGaD
Nicardipine—CALM2—Metabolism—PTEN—malignant glioma	3.51e-06	1.5e-05	CbGpPWpGaD
Nicardipine—CALM1—Metabolism—PTEN—malignant glioma	3.51e-06	1.5e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling by GPCR—PIK3CA—malignant glioma	3.51e-06	1.5e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling by GPCR—PIK3CA—malignant glioma	3.51e-06	1.5e-05	CbGpPWpGaD
Nicardipine—CHRM2—Signaling by GPCR—AKT1—malignant glioma	3.5e-06	1.49e-05	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling by GPCR—AKT1—malignant glioma	3.49e-06	1.49e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—MDM2—malignant glioma	3.49e-06	1.49e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—MDM2—malignant glioma	3.49e-06	1.49e-05	CbGpPWpGaD
Nicardipine—CALM2—Immune System—KRAS—malignant glioma	3.49e-06	1.49e-05	CbGpPWpGaD
Nicardipine—CALM1—Immune System—KRAS—malignant glioma	3.49e-06	1.49e-05	CbGpPWpGaD
Nicardipine—CALM2—Disease—MYC—malignant glioma	3.48e-06	1.49e-05	CbGpPWpGaD
Nicardipine—CALM1—Disease—MYC—malignant glioma	3.48e-06	1.49e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—RAF1—malignant glioma	3.48e-06	1.49e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—RAF1—malignant glioma	3.48e-06	1.49e-05	CbGpPWpGaD
Nicardipine—CYP3A4—Metabolism—NCOR1—malignant glioma	3.45e-06	1.47e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—ERBB2—malignant glioma	3.44e-06	1.47e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—ERBB2—malignant glioma	3.44e-06	1.47e-05	CbGpPWpGaD
Nicardipine—CYP2D6—Metabolism—PIK3CD—malignant glioma	3.44e-06	1.47e-05	CbGpPWpGaD
Nicardipine—ADRA1D—Signaling Pathways—PIK3CA—malignant glioma	3.43e-06	1.46e-05	CbGpPWpGaD
Nicardipine—CYP2C9—Metabolism—PIK3CD—malignant glioma	3.41e-06	1.46e-05	CbGpPWpGaD
Nicardipine—CALM2—Disease—EGFR—malignant glioma	3.41e-06	1.45e-05	CbGpPWpGaD
Nicardipine—CALM1—Disease—EGFR—malignant glioma	3.41e-06	1.45e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—PIK3CB—malignant glioma	3.4e-06	1.45e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—PIK3CB—malignant glioma	3.4e-06	1.45e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—CXCL8—malignant glioma	3.38e-06	1.44e-05	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling Pathways—MYC—malignant glioma	3.35e-06	1.43e-05	CbGpPWpGaD
Nicardipine—CALM3—Disease—KRAS—malignant glioma	3.33e-06	1.42e-05	CbGpPWpGaD
Nicardipine—ADRA1D—Signaling Pathways—TP53—malignant glioma	3.31e-06	1.41e-05	CbGpPWpGaD
Nicardipine—CALM3—Immune System—PIK3CA—malignant glioma	3.31e-06	1.41e-05	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—VEGFA—malignant glioma	3.28e-06	1.4e-05	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling Pathways—EGFR—malignant glioma	3.28e-06	1.4e-05	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—VEGFA—malignant glioma	3.27e-06	1.4e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—CXCL8—malignant glioma	3.26e-06	1.39e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—CXCL8—malignant glioma	3.26e-06	1.39e-05	CbGpPWpGaD
Nicardipine—CYP2C19—Metabolism—PIK3CB—malignant glioma	3.26e-06	1.39e-05	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—STAT3—malignant glioma	3.25e-06	1.39e-05	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—VEGFA—malignant glioma	3.24e-06	1.38e-05	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—STAT3—malignant glioma	3.24e-06	1.38e-05	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—VEGFA—malignant glioma	3.23e-06	1.38e-05	CbGpPWpGaD
Nicardipine—CYP2C19—Metabolism—PTGS2—malignant glioma	3.23e-06	1.38e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—CASP3—malignant glioma	3.23e-06	1.38e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—IL2—malignant glioma	3.23e-06	1.38e-05	CbGpPWpGaD
Nicardipine—CALM2—Disease—KRAS—malignant glioma	3.22e-06	1.37e-05	CbGpPWpGaD
Nicardipine—CALM1—Disease—KRAS—malignant glioma	3.22e-06	1.37e-05	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—STAT3—malignant glioma	3.21e-06	1.37e-05	CbGpPWpGaD
Nicardipine—CALM2—Immune System—PIK3CA—malignant glioma	3.2e-06	1.37e-05	CbGpPWpGaD
Nicardipine—CALM1—Immune System—PIK3CA—malignant glioma	3.2e-06	1.37e-05	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—STAT3—malignant glioma	3.2e-06	1.37e-05	CbGpPWpGaD
Nicardipine—ABCB1—Metabolism—PIK3CB—malignant glioma	3.18e-06	1.36e-05	CbGpPWpGaD
Nicardipine—CYP2C8—Metabolism—PTEN—malignant glioma	3.16e-06	1.35e-05	CbGpPWpGaD
Nicardipine—ABCB1—Metabolism—PTGS2—malignant glioma	3.15e-06	1.35e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—CASP3—malignant glioma	3.12e-06	1.33e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—CASP3—malignant glioma	3.12e-06	1.33e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—IL2—malignant glioma	3.12e-06	1.33e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—IL2—malignant glioma	3.12e-06	1.33e-05	CbGpPWpGaD
Nicardipine—CHRM4—Signaling Pathways—AKT1—malignant glioma	3.11e-06	1.33e-05	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling Pathways—KRAS—malignant glioma	3.09e-06	1.32e-05	CbGpPWpGaD
Nicardipine—CHRM3—Metabolism—PIK3CA—malignant glioma	3.06e-06	1.31e-05	CbGpPWpGaD
Nicardipine—CALM3—Disease—PIK3CA—malignant glioma	3.06e-06	1.31e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—MMP9—malignant glioma	3.05e-06	1.3e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—PTEN—malignant glioma	3.03e-06	1.3e-05	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—MYC—malignant glioma	3.02e-06	1.29e-05	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—MYC—malignant glioma	3.01e-06	1.29e-05	CbGpPWpGaD
Nicardipine—CYP2D6—Metabolism—PIK3CB—malignant glioma	3e-06	1.28e-05	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—MYC—malignant glioma	2.98e-06	1.27e-05	CbGpPWpGaD
Nicardipine—CHRM5—Signaling Pathways—AKT1—malignant glioma	2.98e-06	1.27e-05	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—MYC—malignant glioma	2.97e-06	1.27e-05	CbGpPWpGaD
Nicardipine—CYP2C9—Metabolism—PIK3CB—malignant glioma	2.97e-06	1.27e-05	CbGpPWpGaD
Nicardipine—CYP2D6—Metabolism—PTGS2—malignant glioma	2.97e-06	1.27e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling by GPCR—AKT1—malignant glioma	2.96e-06	1.26e-05	CbGpPWpGaD
Nicardipine—CALM1—Disease—PIK3CA—malignant glioma	2.96e-06	1.26e-05	CbGpPWpGaD
Nicardipine—CALM2—Disease—PIK3CA—malignant glioma	2.96e-06	1.26e-05	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—EGFR—malignant glioma	2.96e-06	1.26e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—MMP9—malignant glioma	2.95e-06	1.26e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—MMP9—malignant glioma	2.95e-06	1.26e-05	CbGpPWpGaD
Nicardipine—CYP2C9—Metabolism—PTGS2—malignant glioma	2.95e-06	1.26e-05	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—EGFR—malignant glioma	2.95e-06	1.26e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—PTEN—malignant glioma	2.94e-06	1.25e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—PTEN—malignant glioma	2.94e-06	1.25e-05	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—EGFR—malignant glioma	2.92e-06	1.25e-05	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—EGFR—malignant glioma	2.91e-06	1.24e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling by GPCR—AKT1—malignant glioma	2.86e-06	1.22e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling by GPCR—AKT1—malignant glioma	2.86e-06	1.22e-05	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling Pathways—PIK3CA—malignant glioma	2.84e-06	1.21e-05	CbGpPWpGaD
Nicardipine—CYP2C19—Metabolism—PTEN—malignant glioma	2.82e-06	1.2e-05	CbGpPWpGaD
Nicardipine—CYP3A4—Metabolism—CAV1—malignant glioma	2.81e-06	1.2e-05	CbGpPWpGaD
Nicardipine—ADRA1D—Signaling Pathways—AKT1—malignant glioma	2.8e-06	1.19e-05	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—KRAS—malignant glioma	2.79e-06	1.19e-05	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—KRAS—malignant glioma	2.78e-06	1.19e-05	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—KRAS—malignant glioma	2.76e-06	1.18e-05	CbGpPWpGaD
Nicardipine—ABCB1—Metabolism—PTEN—malignant glioma	2.75e-06	1.17e-05	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling Pathways—TP53—malignant glioma	2.75e-06	1.17e-05	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—KRAS—malignant glioma	2.75e-06	1.17e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—VEGFA—malignant glioma	2.74e-06	1.17e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—STAT3—malignant glioma	2.71e-06	1.16e-05	CbGpPWpGaD
Nicardipine—CALM3—Immune System—AKT1—malignant glioma	2.71e-06	1.15e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—VEGFA—malignant glioma	2.65e-06	1.13e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—VEGFA—malignant glioma	2.65e-06	1.13e-05	CbGpPWpGaD
Nicardipine—CYP2B6—Metabolism—PIK3CA—malignant glioma	2.63e-06	1.12e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—STAT3—malignant glioma	2.63e-06	1.12e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—STAT3—malignant glioma	2.63e-06	1.12e-05	CbGpPWpGaD
Nicardipine—CALM1—Immune System—AKT1—malignant glioma	2.62e-06	1.12e-05	CbGpPWpGaD
Nicardipine—CALM2—Immune System—AKT1—malignant glioma	2.62e-06	1.12e-05	CbGpPWpGaD
Nicardipine—CYP2D6—Metabolism—PTEN—malignant glioma	2.59e-06	1.11e-05	CbGpPWpGaD
Nicardipine—CYP2E1—Metabolism—PIK3CA—malignant glioma	2.58e-06	1.1e-05	CbGpPWpGaD
Nicardipine—CYP3A5—Metabolism—PIK3CA—malignant glioma	2.57e-06	1.1e-05	CbGpPWpGaD
Nicardipine—CYP2C9—Metabolism—PTEN—malignant glioma	2.57e-06	1.1e-05	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—PIK3CA—malignant glioma	2.57e-06	1.1e-05	CbGpPWpGaD
Nicardipine—CALM3—Metabolism—PIK3CA—malignant glioma	2.56e-06	1.09e-05	CbGpPWpGaD
Nicardipine—CYP3A4—Metabolism—PIK3CG—malignant glioma	2.56e-06	1.09e-05	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—PIK3CA—malignant glioma	2.56e-06	1.09e-05	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—PIK3CA—malignant glioma	2.53e-06	1.08e-05	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—PIK3CA—malignant glioma	2.53e-06	1.08e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—MYC—malignant glioma	2.52e-06	1.08e-05	CbGpPWpGaD
Nicardipine—CHRM3—Metabolism—AKT1—malignant glioma	2.5e-06	1.07e-05	CbGpPWpGaD
Nicardipine—CALM3—Disease—AKT1—malignant glioma	2.5e-06	1.07e-05	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—TP53—malignant glioma	2.48e-06	1.06e-05	CbGpPWpGaD
Nicardipine—CALM2—Metabolism—PIK3CA—malignant glioma	2.48e-06	1.06e-05	CbGpPWpGaD
Nicardipine—CALM1—Metabolism—PIK3CA—malignant glioma	2.48e-06	1.06e-05	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—TP53—malignant glioma	2.47e-06	1.06e-05	CbGpPWpGaD
Nicardipine—CYP3A4—Metabolism—PPARG—malignant glioma	2.47e-06	1.05e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—EGFR—malignant glioma	2.47e-06	1.05e-05	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—TP53—malignant glioma	2.45e-06	1.05e-05	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—TP53—malignant glioma	2.44e-06	1.04e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—MYC—malignant glioma	2.44e-06	1.04e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—MYC—malignant glioma	2.44e-06	1.04e-05	CbGpPWpGaD
Nicardipine—CALM2—Disease—AKT1—malignant glioma	2.42e-06	1.03e-05	CbGpPWpGaD
Nicardipine—CALM1—Disease—AKT1—malignant glioma	2.42e-06	1.03e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—EGFR—malignant glioma	2.39e-06	1.02e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—EGFR—malignant glioma	2.39e-06	1.02e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—KRAS—malignant glioma	2.33e-06	9.95e-06	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling Pathways—AKT1—malignant glioma	2.32e-06	9.91e-06	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—KRAS—malignant glioma	2.25e-06	9.62e-06	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—KRAS—malignant glioma	2.25e-06	9.62e-06	CbGpPWpGaD
Nicardipine—CYP3A4—Metabolism—PIK3CD—malignant glioma	2.25e-06	9.6e-06	CbGpPWpGaD
Nicardipine—CYP2C8—Metabolism—PIK3CA—malignant glioma	2.23e-06	9.51e-06	CbGpPWpGaD
Nicardipine—CYP2B6—Metabolism—AKT1—malignant glioma	2.15e-06	9.17e-06	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—PIK3CA—malignant glioma	2.14e-06	9.14e-06	CbGpPWpGaD
Nicardipine—CYP2E1—Metabolism—AKT1—malignant glioma	2.11e-06	8.99e-06	CbGpPWpGaD
Nicardipine—CYP3A5—Metabolism—AKT1—malignant glioma	2.1e-06	8.97e-06	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—AKT1—malignant glioma	2.1e-06	8.95e-06	CbGpPWpGaD
Nicardipine—CALM3—Metabolism—AKT1—malignant glioma	2.09e-06	8.93e-06	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—AKT1—malignant glioma	2.09e-06	8.92e-06	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—TP53—malignant glioma	2.07e-06	8.84e-06	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—PIK3CA—malignant glioma	2.07e-06	8.84e-06	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—PIK3CA—malignant glioma	2.07e-06	8.84e-06	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—AKT1—malignant glioma	2.07e-06	8.83e-06	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—AKT1—malignant glioma	2.06e-06	8.81e-06	CbGpPWpGaD
Nicardipine—CALM1—Metabolism—AKT1—malignant glioma	2.02e-06	8.64e-06	CbGpPWpGaD
Nicardipine—CALM2—Metabolism—AKT1—malignant glioma	2.02e-06	8.64e-06	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—TP53—malignant glioma	2e-06	8.55e-06	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—TP53—malignant glioma	2e-06	8.55e-06	CbGpPWpGaD
Nicardipine—CYP2C19—Metabolism—PIK3CA—malignant glioma	1.99e-06	8.49e-06	CbGpPWpGaD
Nicardipine—CYP3A4—Metabolism—PIK3CB—malignant glioma	1.96e-06	8.37e-06	CbGpPWpGaD
Nicardipine—CYP3A4—Metabolism—PTGS2—malignant glioma	1.94e-06	8.29e-06	CbGpPWpGaD
Nicardipine—ABCB1—Metabolism—PIK3CA—malignant glioma	1.94e-06	8.28e-06	CbGpPWpGaD
Nicardipine—CYP2D6—Metabolism—PIK3CA—malignant glioma	1.83e-06	7.81e-06	CbGpPWpGaD
Nicardipine—CYP2C8—Metabolism—AKT1—malignant glioma	1.82e-06	7.77e-06	CbGpPWpGaD
Nicardipine—CYP2C9—Metabolism—PIK3CA—malignant glioma	1.81e-06	7.74e-06	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—AKT1—malignant glioma	1.75e-06	7.47e-06	CbGpPWpGaD
Nicardipine—CYP3A4—Metabolism—PTEN—malignant glioma	1.69e-06	7.23e-06	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—AKT1—malignant glioma	1.69e-06	7.22e-06	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—AKT1—malignant glioma	1.69e-06	7.22e-06	CbGpPWpGaD
Nicardipine—CYP2C19—Metabolism—AKT1—malignant glioma	1.62e-06	6.93e-06	CbGpPWpGaD
Nicardipine—ABCB1—Metabolism—AKT1—malignant glioma	1.59e-06	6.77e-06	CbGpPWpGaD
Nicardipine—CYP2D6—Metabolism—AKT1—malignant glioma	1.49e-06	6.38e-06	CbGpPWpGaD
Nicardipine—CYP2C9—Metabolism—AKT1—malignant glioma	1.48e-06	6.32e-06	CbGpPWpGaD
Nicardipine—CYP3A4—Metabolism—PIK3CA—malignant glioma	1.2e-06	5.1e-06	CbGpPWpGaD
Nicardipine—CYP3A4—Metabolism—AKT1—malignant glioma	9.77e-07	4.17e-06	CbGpPWpGaD
